Eversept Partners, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001697013

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 111 positions · Total reported value $1.86B · Top-10 concentration 50.3% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.5% · 24 new · 32 cut · 32 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -9.4% · vs SPY -11.5% · Prev Value $1.91B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.0% · vs SPY -2.2% · Latest Value $1.86B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Eversept Partners, LP disclosed 111 equity positions with a combined reported value of $1.86B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 50.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were UTHR ($175.97M), EHC ($131.49M), ENSG ($124.90M). By sector, the heaviest allocations are Health Care 79.0%, Real Estate 7.0%. Versus the prior quarter, allocation shifted toward Industrials (+5.2pp), Other (+2.5pp) and away from Consumer Discretionary (-0.7pp), Health Care (-9.3pp).

Versus the prior quarter, Eversept Partners, LP opened 24 new positions, trimmed 32 and fully exited 32, a turnover rate of 61.5% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2026 were GH ($45.74M), WAT ($33.14M), GRAL ($25.52M).

Of the 32 positions fully exited versus the prior quarter, the largest were GSK ($25.26M), LLY ($24.13M), AMN ($13.87M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • GH GUARDANT HEALTH INC · $45.74M
  • WAT WATERS CORP · $33.14M
  • GRAL GRAIL INC · $25.52M
  • GDRX GOODRX HLDGS INC · $16.51M
  • ROIV ROIVANT SCIENCES LTD · $15.33M
  • SPY STATE STR SPDR S&P 500 ETF T · $15.25M
  • SUPN SUPERNUS PHARMACEUTICALS · $14.97M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · $10.22M

Fully Exited (vs previous quarter)

  • GSK GSK PLC · prev qtr: $25.26M
  • LLY ELI LILLY & CO · prev qtr: $24.13M
  • AMN AMN HEALTHCARE SVCS INC · prev qtr: $13.87M
  • CELC CELCUITY INC · prev qtr: $13.38M
  • HUM HUMANA INC · prev qtr: $12.38M
  • ASND ASCENDIS PHARMA A/S · prev qtr: $11.10M
  • MRNA MODERNA INC · prev qtr: $10.65M
  • DFTX DEFINIUM THERAPEUTICS INC · prev qtr: $10.22M

Insider Transactions (Form 4)

Latest Eversept Partners, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eversept Partners, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 119 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108771 (status: Approved), registered 2017-01-11
  • Regulatory AUM (Form ADV): $2.65B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 99%, registered investment companies 1%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: eversept.com

Portfolio Structure

  • 119 positions · $1.91B reported value (Q2 2026)
  • Top 10 holdings = 46.1% of reported value
  • Largest position: UTHR (UNITED THERAPEUTICS CORP DEL) at 8.2%
  • Average position size: $16.06M

Sector Tilt

  • Health Care 88.2%
  • Real Estate 5.6%
  • Industrials 1.3%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 29 new, 42 added, 41 reduced, 27 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.0%
Technology 0.9%
Financials 0.0%
Other 6.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 324.73K $175.97M 9.46%
9.46%
Add
2 1.08M $131.49M 7.07%
7.07%
Add
3 726.19K $124.90M 6.71%
6.71%
Add
4 1.10M $108.99M 5.86%
5.86%
Add
5 135.00K $99.87M 5.37%
5.37%
Add
6 2.36M $76.27M 4.10%
4.10%
Add
7 449.79K $68.77M 3.70%
3.70%
Add
8 128.13K $52.96M 2.85%
2.85%
Reduce
9 1.35M $49.48M 2.66%
2.66%
Add
10 1.01M $46.71M 2.51%
2.51%
Add
11 2.44M $45.93M 2.47%
2.47%
Reduce
12 256.43K $45.74M 2.46%
2.46%
New
13 1.17M $38.07M 2.05%
2.05%
Reduce
14 75.42K $33.14M 1.78%
1.78%
New
15 1.01M $32.81M 1.76%
1.76%
Add
16 2.87M $31.05M 1.67%
1.67%
Reduce
17 68.32K $29.15M 1.57%
1.57%
Reduce
18 509.24K $28.98M 1.56%
1.56%
Reduce
19 453.87K $26.72M 1.44%
1.44%
Reduce
20 9.14M $26.13M 1.41%
1.41%
Add
21 182.15K $25.52M 1.37%
1.37%
New
22 18.53M $22.79M 1.23%
1.23%
Reduce
23 43.91K $22.18M 1.19%
1.19%
Reduce
24 536.05K $20.91M 1.12%
1.12%
Add
25 458.00K $19.63M 1.05%
1.05%
Add
26 1.02M $19.43M 1.04%
1.04%
Reduce
27 641.99K $19.43M 1.04%
1.04%
Add
28 160.81K $18.35M 0.99%
0.99%
Add
29 304.84K $18.29M 0.98%
0.98%
Add
30 279.85K $18.12M 0.97%
0.97%
Add
31 70.42K $18.00M 0.97%
0.97%
Reduce
32 5.02M $16.51M 0.89%
0.89%
New
33 480.11K $15.37M 0.83%
0.83%
Reduce
34 419.14K $15.33M 0.82%
0.82%
New
35 20.00K $15.25M 0.82%
0.82%
New
36 347.86K $14.97M 0.81%
0.81%
New
37 100.97K $13.17M 0.71%
0.71%
Reduce
38 64.82K $12.46M 0.67%
0.67%
Add
39 681.71K $12.30M 0.66%
0.66%
Add
40 46.19K $10.63M 0.57%
0.57%
Reduce
41 156.22K $10.22M 0.55%
0.55%
New
42 129.28K $10.16M 0.55%
0.55%
Add
43 3.54M $9.64M 0.52%
0.52%
Hold
44 526.65K $8.91M 0.48%
0.48%
New
45 211.74K $8.80M 0.47%
0.47%
Add
46 265.12K $8.41M 0.45%
0.45%
Reduce
47 154.92K $7.79M 0.42%
0.42%
Add
48 39.38K $7.45M 0.40%
0.40%
Reduce
49 484.05K $7.28M 0.39%
0.39%
Add
50 193.16K $7.26M 0.39%
0.39%
Add

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)

Low-confidence forecast This fund replaces about 24% of its Top-10 each quarter and backtests at F1 77% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 77% · recall 77% · F1 77% · avg rank error 2.3 · Top-10 turnover 24%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% NTRA · GSK · INSP · SNDX · TEVA · QQQ · UTHR · SPY · TECH · ARGX NTRA · GSK · QQQ · INSP · TEVA · VERA · SNDX · UTHR · RVTY · TECH
2024-Q2 90% 90% 90% GSK · NTRA · QQQ · INSP · TEVA · VERA · SNDX · RVTY · UTHR · TECH QQQ · GSK · NTRA · INSM · TEVA · UTHR · SNDX · VERA · INSP · RVTY
2024-Q3 90% 90% 90% QQQ · GSK · NTRA · INSM · UTHR · INSP · SNDX · TEVA · VERA · RVTY GSK · QQQ · NTRA · VERA · INSM · SNDX · RVTY · INSP · TEVA · CYH
2024-Q4 80% 80% 80% GSK · QQQ · NTRA · VERA · SNDX · INSM · RVTY · INSP · HCA · TEVA NTRA · QQQ · GSK · VERA · INSP · HCA · TEVA · RVTY · HQY · ZIMV
2025-Q1 70% 70% 70% NTRA · GSK · QQQ · VERA · HCA · INSP · TEVA · RVTY · HQY · ZIMV NTRA · GSK · HCA · SNDX · VERA · SPY · RVTY · HQY · INSP · PTGX
2025-Q2 60% 60% 60% NTRA · GSK · SNDX · HCA · SPY · VERA · HQY · RVTY · INSP · PTGX NTRA · QQQ · GSK · VERA · RVTY · PCVX · HCA · SNDX · BRKR · VRDN
2025-Q3 80% 80% 80% NTRA · QQQ · GSK · VERA · RVTY · PCVX · SNDX · BRKR · HCA · VRDN QQQ · GSK · NTRA · VERA · SNDX · PCVX · QURE · HCA · VRDN · ZIMV
2025-Q4 70% 70% 70% QQQ · GSK · VERA · NTRA · PCVX · SNDX · QURE · HCA · VRDN · ZIMV VERA · QQQ · GSK · UTHR · ABVX · NTRA · SNDX · VRDN · PCVX · TVTX
2026-Q1 80% 80% 80% VERA · QQQ · UTHR · GSK · ABVX · NTRA · SNDX · VRDN · PCVX · DHR UTHR · QQQ · ABVX · GSK · VERA · NTRA · SPY · SNDX · CLDX · PCVX
2026-Q2 ★ 70% 70% 70% UTHR · QQQ · ABVX · GSK · VERA · SPY · NTRA · SNDX · CLDX · BKD UTHR · ABVX · EHC · ENSG · VERA · QQQ · CLDX · SNDX · BKD · IONS

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings22 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+2.75%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+16.46%vs benchmark
Barra annualised vol25.0%Model estimate
Realised vol25.2%Annualised in window
Weighted beta0.79Raw exposure
Factor / specific risk66% / 34%Share of variance
Top-10 concentration87.0%Of reported value
Portfolio value (start = 100)78.086.094.0101.9109.910-0110-2311-13Eversept Partners, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+2.75%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+16.46%Portfolio − benchmark
Arithmetic return sum+3.11%Difference vs compounded is the cross term
Weighted raw beta0.79Weighted holding betas
Realised volatility (annualised)25.16%Daily returns in window
Barra model volatility (annualised)24.98%Factor + specific
Factor share of variance65.5%Barra factors
Specific share of variance34.5%Stock residuals
Reported value$592.8M13F long US equity

2. Return attribution

The +3.11% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +3.61% 116.1%
Momentum & Growth 3 -1.94% -62.5%
Volatility & Tail Risk 7 +2.66% 85.8%
Industry 12 +8.11% 261.1%
Specific 1 -9.33% -300.5%
Return attribution (style + industry, %)-10.0-5.0+0.0+5.0+10.0Size+0.55Short-term Reversal-0.67Max Drawdown-0.76Growth+0.94Leverage (Downside Vol)+1.13Residual Volatility+1.20Non-linear Size+1.37Other+1.95Momentum-2.21Turnover+2.24Historical Volatility-2.48Skewness-5.30Health Care+5.94Kurtosis+9.22
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +1.32 +6.97% +9.22% 296.9%
Health Care Industry +0.73 +8.12% +5.94% 191.1%
Turnover Style -0.47 -4.77% +2.24% 72.0%
Other Industry +0.19 +10.06% +1.95% 62.9%
Non-linear Size Style +1.50 +0.91% +1.37% 44.1%
Residual Volatility Style +0.45 +2.66% +1.20% 38.8%
Leverage (Downside Vol) Style -0.62 -1.82% +1.13% 36.4%
Growth Style +0.60 +1.57% +0.94% 30.3%
Size Style -0.30 -1.83% +0.55% 17.8%
Liquidity Style +0.80 +0.22% +0.17% 5.6%
Industrials Industry +0.06 +2.04% +0.12% 3.7%
Real Estate Industry +0.02 +5.90% +0.11% 3.4%
Mid Cap Style +0.16 -1.69% -0.27% -8.6%
Beta Style -0.07 +4.85% -0.36% -11.4%
Amihud Illiquidity Style +1.14 -0.40% -0.46% -14.8%
Short-term Reversal Style -0.85 +0.79% -0.67% -21.5%
Max Drawdown Style +0.39 -1.96% -0.76% -24.6%
Momentum Style +0.66 -3.34% -2.21% -71.3%
Historical Volatility Style +0.19 -12.86% -2.48% -79.9%
Skewness Style +1.26 -4.21% -5.30% -170.5%
Specific Specific — — -9.33% -300.5%

3. Risk attribution

Annualised volatility is 24.98%; factor risk explains 65.5% of variance and specific risk 34.5%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-37.3-18.7+0.0+18.7+37.3Max Drawdown-1.17Growth-1.14Non-linear Size+1.14Industrials+1.27Amihud Illiquidity+1.61Residual Volatility+2.19Short-term Reversal+4.99Momentum+5.19Kurtosis+5.26Liquidity+5.31Skewness+6.39Other+10.63Health Care+23.08Specific+34.54
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 34.5% +8.63% 8.6%
Health Care Industry +0.73 23.1% +5.77% 5.8%
Other Industry +0.19 10.6% +2.65% 2.6%
Skewness Style +1.26 6.4% +1.60% 1.6%
Liquidity Style +0.80 5.3% +1.33% 1.3%
Kurtosis Style +1.32 5.3% +1.31% 1.3%
Momentum Style +0.66 5.2% +1.30% 1.3%
Short-term Reversal Style -0.85 5.0% +1.25% 1.2%
Residual Volatility Style +0.45 2.2% +0.55% 0.6%
Amihud Illiquidity Style +1.14 1.6% +0.40% 0.4%
Industrials Industry +0.06 1.3% +0.32% 0.3%
Non-linear Size Style +1.50 1.1% +0.28% 0.3%
Historical Volatility Style +0.19 0.8% +0.19% 0.2%
Size Style -0.30 0.7% +0.16% 0.2%
Turnover Style -0.47 0.4% +0.10% 0.1%
Real Estate Industry +0.02 0.3% +0.09% 0.1%
Mid Cap Style +0.16 0.3% +0.07% 0.1%
Beta Style -0.07 -0.8% -0.19% -0.2%
Leverage (Downside Vol) Style -0.62 -1.0% -0.24% -0.2%
Growth Style +0.60 -1.1% -0.28% -0.3%
Max Drawdown Style +0.39 -1.2% -0.29% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.1-0.30.61.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.30 +2.10 -2.40
Non-linear Size +1.50 +1.68 -0.18
Mid Cap +0.16 +0.13 +0.03
Beta -0.07 +1.29 -1.37
Momentum +0.66 +0.72 -0.05
Short-term Reversal -0.85 -0.64 -0.21
Residual Volatility +0.45 -0.40 +0.85
Historical Volatility +0.19 +0.86 -0.67
Liquidity +0.80 +0.11 +0.69
Amihud Illiquidity +1.14 +1.16 -0.02
Turnover -0.47 +0.21 -0.68
Growth +0.60 +0.58 +0.02
Leverage (Downside Vol) -0.62 +0.14 -0.76
Skewness +1.26 +0.24 +1.02
Kurtosis +1.32 +0.21 +1.11
Max Drawdown +0.39 -0.08 +0.47

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryReal EstateIndustrialsOtherHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Health Care 73.1% 1.7% +3.04% +9.16% +16.04% -0.11% -4.37% +2.06%
Other 19.4% 0.0% +2.62% +0.00% +2.58% +0.00% +0.51% +0.51%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Real Estate 1.8% 0.0% +6.18% +0.00% +0.24% +0.00% +0.11% +0.11%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 5.7% 11.1% +4.62% +7.16% -1.11% -0.28% +0.14% -0.53%
Total +19.93% +13.39% -17.39% +15.93%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
UTHR UNITED THERAPEUTICS CORP DEL Health Care 29.68% +9.09% +2.70% Add
QQQ INVESCO QQQ TR Other 16.85% +2.69% +0.45% Add
NTRA NATERA INC Health Care 8.93% -22.80% -2.04% Reduce
GH GUARDANT HEALTH INC Health Care 7.72% -14.95% -1.15% New
WAT WATERS CORP Industrials 5.59% +4.75% +0.27% New
HCA HCA HEALTHCARE INC Health Care 4.92% +16.95% +0.83% Reduce
GRAL GRAIL INC Health Care 4.31% -17.29% -0.74% New
LQDA LIQUIDIA CORPORATION Health Care 3.28% +89.72% +2.94% Add
INSM INSMED INC Health Care 3.10% +6.15% +0.19% Add
ROIV ROIVANT SCIENCES LTD Health Care 2.59% +8.09% +0.21% New
SPY STATE STR SPDR S&P 500 ETF T Other 2.57% +2.16% +0.06% New
RGEN REPLIGEN CORP Health Care 2.10% -12.71% -0.27% Add
RLAY RELAY THERAPEUTICS INC Health Care 2.08% +0.22% +0.01% Add
WELL WELLTOWER INC Real Estate 1.79% +6.18% +0.11% Reduce
UNH UNITEDHEALTH GROUP INC Health Care 1.19% +11.00% +0.13% Reduce
NAMS NEWAMSTERDAM PHARMA COMPANY Health Care 0.92% -17.19% -0.16% Reduce
GPCR STRUCTURE THERAPEUTICS INC Health Care 0.82% -36.04% -0.29% Reduce
BEAM BEAM THERAPEUTICS INC Health Care 0.53% -6.63% -0.03% Reduce
CTNM CONTINEUM THERAPEUTICS INC Health Care 0.45% -26.53% -0.12% Add
ISRG INTUITIVE SURGICAL INC Health Care 0.25% +9.09% +0.02% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 LQDA Health Care 3.28% +89.72% +2.94%
2 UTHR Health Care 29.68% +9.09% +2.70%
3 HCA Health Care 4.92% +16.95% +0.83%
4 QQQ Other 16.85% +2.69% +0.45%
5 WAT Industrials 5.59% +4.75% +0.27%
6 ROIV Health Care 2.59% +8.09% +0.21%
7 INSM Health Care 3.10% +6.15% +0.19%
8 UNH Health Care 1.19% +11.00% +0.13%
9 RGEN Health Care 2.10% -12.71% -0.27%
10 GPCR Health Care 0.82% -36.04% -0.29%
11 GRAL Health Care 4.31% -17.29% -0.74%
12 GH Health Care 7.72% -14.95% -1.15%
13 NTRA Health Care 8.93% -22.80% -2.04%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +2.75%, versus -13.72% for the QQQ synthetic benchmark — an excess of +16.46%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +9.22%, Health Care +5.94%, Turnover +2.24%; the largest drags came from Skewness -5.30%, Historical Volatility -2.48%, Momentum -2.21%. Specific (stock-level) return contributed -9.33%.
  3. Risk attribution: Barra model volatility is 24.98% annualised; factor risk explains 65% of variance and specific risk 35%. The largest factor risk sources are Health Care 23.1%, Other 10.6%, Skewness 6.4%.
  4. Style tilt: size -0.30, momentum +0.66, volatility +0.19, liquidity +0.80; the weighted raw beta is 0.79. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+71.4 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +19.93%, selection +13.39% and interaction -17.39%.
  6. Concentration: the top-10 positions are 87.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Eversept Partners, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Eversept Partners, LP reported 111 equity positions worth $1.86B in aggregate; its largest disclosed positions were UTHR ($175.97M), EHC ($131.49M), ENSG ($124.90M).

How large is Eversept Partners, LP's portfolio?

Eversept Partners, LP reported $1.86B of long equity holdings across 111 positions as of 2026-Q3. Top-10 holdings account for 50.3% of reported value.

What is Eversept Partners, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eversept-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →